C P Wheeler-Jones - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

C P Wheeler-Jones

Showing results (11-20 of 22) with videos related to

Pageof 3

Sort By:

FEBS Letters|June 17, 1996

Inhibition of MAP kinase kinase (MEK) blocks endothelial PGI2 release but has no effect on von Willebrand factor secretion or E-selectin expressionC P Wheeler-Jones, M J May, R A Houliston, et al.

Molecular and Cellular Endocrinology|July 1, 1993

Mastoparan stimulates insulin secretion from pancreatic beta-cells by effects at a late stage in the secretory pathwayP M Jones, F M Mann, S J Persaud, et al.

The American Journal of Physiology|April 8, 1998

Activation of p42mapk in human umbilical vein endothelial cells by interleukin-1 alpha and tumor necrosis factor-alphaM J May, C P Wheeler-Jones, R A Houliston, et al.

Biochemical and Biophysical Research Communications|September 29, 1989

The fibrinogen-derived peptide (RGDS) prevents proteolytic degradation of protein kinase C in platelets by inhibiting platelet aggregationS Krishnamurthi, T A Dickens, Y Patel, et al.

FEBS Letters|July 31, 1989

Na+/H+ exchange is not necessary for protein kinase C-mediated effects in plateletsS Krishnamurthi, Y Patel, W A Morgan, et al.

British Journal of Pharmacology|April 1, 1996

Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing propertiesG Cirino, C P Wheeler-Jones, J L Wallace, et al.

Matrix Biology : Journal of the International Society for Matrix Biology|February 5, 2011

Reduced chondrogenic matrix accumulation by 4-methylumbelliferone reveals the potential for selective targeting of UDP-glucose dehydrogenaseC E Clarkin, S Allen, C P Wheeler-Jones, et al.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 8, 2001

Mechanical strain and estrogen activate estrogen receptor alpha in bone cellsH L Jessop, M Sjöberg, M Z Cheng, et al.

Biochemical and Biophysical Research Communications|July 15, 1994

Thrombin receptor activating peptide does not stimulate platelet procoagulant activityC A Goodwin, C P Wheeler-Jones, V V Kakkar, et al.

The Biochemical Journal|May 15, 1995

Increased expression of procoagulant activity on the surface of human platelets exposed to heavy-metal compoundsC A Goodwin, C P Wheeler-Jones, S Namiranian, et al.

Pageof 3

Search research articles

Showing results (11-20 of 22) with videos related to

Sort By:

Pageof 3

FEBS Letters|June 17, 1996

Inhibition of MAP kinase kinase (MEK) blocks endothelial PGI2 release but has no effect on von Willebrand factor secretion or E-selectin expressionC P Wheeler-Jones, M J May, R A Houliston, et al.

Molecular and Cellular Endocrinology|July 1, 1993

Mastoparan stimulates insulin secretion from pancreatic beta-cells by effects at a late stage in the secretory pathwayP M Jones, F M Mann, S J Persaud, et al.

The American Journal of Physiology|April 8, 1998

Activation of p42mapk in human umbilical vein endothelial cells by interleukin-1 alpha and tumor necrosis factor-alphaM J May, C P Wheeler-Jones, R A Houliston, et al.

Biochemical and Biophysical Research Communications|September 29, 1989

The fibrinogen-derived peptide (RGDS) prevents proteolytic degradation of protein kinase C in platelets by inhibiting platelet aggregationS Krishnamurthi, T A Dickens, Y Patel, et al.

FEBS Letters|July 31, 1989

Na+/H+ exchange is not necessary for protein kinase C-mediated effects in plateletsS Krishnamurthi, Y Patel, W A Morgan, et al.

British Journal of Pharmacology|April 1, 1996

Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing propertiesG Cirino, C P Wheeler-Jones, J L Wallace, et al.

Matrix Biology : Journal of the International Society for Matrix Biology|February 5, 2011

Reduced chondrogenic matrix accumulation by 4-methylumbelliferone reveals the potential for selective targeting of UDP-glucose dehydrogenaseC E Clarkin, S Allen, C P Wheeler-Jones, et al.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 8, 2001

Mechanical strain and estrogen activate estrogen receptor alpha in bone cellsH L Jessop, M Sjöberg, M Z Cheng, et al.

Biochemical and Biophysical Research Communications|July 15, 1994

Thrombin receptor activating peptide does not stimulate platelet procoagulant activityC A Goodwin, C P Wheeler-Jones, V V Kakkar, et al.

The Biochemical Journal|May 15, 1995

Increased expression of procoagulant activity on the surface of human platelets exposed to heavy-metal compoundsC A Goodwin, C P Wheeler-Jones, S Namiranian, et al.

Pageof 3